Athira Pharma Inc. (LONA)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
7. 22
-0.59
-7.5544%
$
36.9M Market Cap
- P/E Ratio
- Div Yield
65,100 Volume
- Eps
$ 7.81
Previous Close Want to track LONA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Athira Pharma Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 150 | $621 | $1,380 | $759 | 122.22% |
| HFT Hui Fai Tam Caitong International Asset Management Co. Ltd. | 6 | $62 | $48.12 | -$13.88 | -22.39% |
 Jim Harding Propel Bio Management LLC | 149,279 | $618,015 | $1.22M | $597,862.45 | 96.74% |
 Jay Annis Annis Gardner Whiting Capital Advisors, LLC | 1,000 | $10,280 | $8,200 | -$2,080 | -20.23% |
 Ian Jameson American Capital Advisory, LLC | 200 | $828 | $1,628 | $800 | 96.62% |
| AH Anders Hove Acorn Capital Advisors LLC | 634,539 | $5.16M | $4.89M | -$270,988.85 | -5.25% |
